NASDAQ:WVE

Wave Life Sciences Stock Insider Trading

Healthcare > Biotechnology

Buy WVE

*Your capital is at risk

$5.76

+0.0700 (+1.23%)

At Close: Jun 03, 2026

WAVE Life Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 72.72. In total, the insiders bought 19.58M and sold 4.78M WVE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	72.72
● Buy	19.58M shares
● Sell	4.78M shares
67% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Mar 26, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 72.72. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 05, 2026 Buy	Share Option (right to buy) A-Award	Francis Chris See Remarks	Officer	232 500 Value: $2.96M
Feb 05, 2026 Buy	Ordinary Shares A-Award	Bolno Paul President And CEO	CEO / President	165 000 Value: $2.10M
Feb 05, 2026 Buy	Ordinary Shares A-Award	Moran Kyle Chief Financial Officer	C-Suite Officer	45 625 Value: $581.7K
Feb 05, 2026 Buy	Share Option (right to buy) A-Award	Moran Kyle Chief Financial Officer	C-Suite Officer	273 750 Value: $3.49M
Feb 05, 2026 Buy	Share Option (right to buy) A-Award	Bolno Paul President And CEO	CEO / President	1 000 000 Value: $12.8M
Feb 05, 2026 Buy	Ordinary Shares A-Award	Francis Chris See Remarks	Officer	38 750 Value: $494.1K
Jan 02, 2026 Buy	Share Option (right to buy) M-Exempt	Francis Chris See Remarks	Officer	9 375 Value: $29.4K
Jan 02, 2026 Sell	Ordinary Shares S-Sale	Francis Chris See Remarks	Officer	8 080 Value: $128.6K
Jan 02, 2026 Buy	Ordinary Shares M-Exempt	Francis Chris See Remarks	Officer	9 375 Value: $29.4K
Jan 02, 2026 Sell	Ordinary Shares S-Sale	Francis Chris See Remarks	Officer	1 295 Value: $21.6K
Dec 11, 2025 Buy	Ordinary Shares P-Purchase	Gsk Plc 10 Percent Owner	10% Owner	1 470 000 Value: $27.9M
Dec 09, 2025 Buy	Share Option (right to buy) A-Award	Moran Kyle Chief Financial Officer	C-Suite Officer	36 000 Value: $294.1K
Dec 09, 2025 Sell	Ordinary Shares S-Sale	Moran Kyle Chief Financial Officer	C-Suite Officer	50 000 Value: $1.00M
Dec 09, 2025 Buy	Ordinary Shares M-Exempt	Moran Kyle Chief Financial Officer	C-Suite Officer	50 000 Value: $524.0K
Dec 09, 2025 Buy	Ordinary Shares M-Exempt	Moran Kyle Chief Financial Officer	C-Suite Officer	36 000 Value: $294.1K
Dec 09, 2025 Sell	Ordinary Shares S-Sale	Moran Kyle Chief Financial Officer	C-Suite Officer	36 Value: $729
Dec 08, 2025 Buy	Share Option (right to buy) A-Award	Moran Kyle Chief Financial Officer	C-Suite Officer	100 000 Value: $314.0K
Dec 08, 2025 Sell	Ordinary Shares S-Sale	Moran Kyle Chief Financial Officer	C-Suite Officer	50 000 Value: $900.0K
Dec 08, 2025 Buy	Ordinary Shares M-Exempt	Moran Kyle Chief Financial Officer	C-Suite Officer	60 000 Value: $169.8K
Dec 08, 2025 Buy	Share Option (right to buy) M-Exempt	Francis Chris See Remarks	Officer	22 500 Value: $63.7K
Dec 08, 2025 Buy	Share Option (right to buy) M-Exempt	Francis Chris See Remarks	Officer	75 000 Value: $235.5K
Dec 08, 2025 Sell	Ordinary Shares S-Sale	Francis Chris See Remarks	Officer	50 000 Value: $800.0K
Dec 08, 2025 Sell	Ordinary Shares S-Sale	Francis Chris See Remarks	Officer	107 400 Value: $1.56M
Dec 08, 2025 Buy	Ordinary Shares M-Exempt	Francis Chris See Remarks	Officer	50 000 Value: $524.0K
Dec 08, 2025 Buy	Share Option (right to buy) M-Exempt	Francis Chris See Remarks	Officer	168 231 Value: $799.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT WAVE LIFE SCIENCES LTD.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the t...

Read Full Profile Here